Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
- 1 December 2007
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 62 (11) , 1217-1227
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorderJournal of Psychopharmacology, 2008
- Orphan Comparisons and Indirect Meta-analysisJournal of Clinical Psychopharmacology, 2005
- Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopramInternational Journal of Geriatric Psychiatry, 2004
- Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action StudyJournal of Clinical Psychopharmacology, 2003
- Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemideInternational Clinical Psychopharmacology, 2003
- Double‐blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly peopleActa Psychiatrica Scandinavica, 1991
- A double-blind, multicentre study of paroxetine and mianserin in depressionActa Psychiatrica Scandinavica, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960